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Abstract 
Introduction – Identification of patients who will benefit from carotid endarterectomy is not entirely 
effective primarily utilising degree of carotid stenosis. We aimed to determine if microembolic signals 
(MES) detected by transcranial Doppler ultrasound (TCD) can provide clinically useful information 
regarding stroke risk in patients with carotid atherosclerosis. 
 
Methods – We performed a meta-analysis of prospective studies. Three analyses were proposed 
investigating MES detection as a predictor of: stroke or TIA, stroke alone, and stroke or TIA but with 
an increased positivity threshold. Subgroup analysis was used to compare pre-operative 
(symptomatic or asymptomatic) patients and peri- or post-operative patients. 
 
Results – 28 studies reported data regarding both MES status and neurological outcome. Of these, 22 
papers reported data on stroke and TIA as an outcome, 19 on stroke alone, and 8 on stroke and TIA 
with increased positivity threshold. At the median pre-test probability of 3.0%, the post-test 
probabilities of a stroke after a positive and negative TCD were 7.1% (95% CI 5 to 10.1) and 1.2% 
(95% CI 0.6 to 2.5) respectively. In addition, the sensitivities and specificities of each outcome 
showed that increasing the threshold for positivity to 10 MES per hour would make TCD a more 
clinically useful tool in peri- and post-operative patients. 
 
Conclusion – TCD provides clinically useful information about stroke risk for patients with carotid 
disease and is technically feasible in the majority of patients. However, the generally weak level of 
evidence constituting this review means definitive recommendations cannot be made. 
 
Keywords – Transcranial Doppler ultrasound; microembolic signals; carotid disease; stroke; transient 
ischaemic attack 
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Introduction  
Management of patients with internal carotid artery stenosis is founded on statistical evidence 
provided by three trials: The North American Symptomatic Carotid Endarterectomy Trial (NASCET), 
European Carotid Surgery Trial (ECST) and Veterans Affairs Cooperative Study (VACS). All used 
degree of internal carotid artery stenosis as the indicator of stroke risk [(1)]. Results showed definitive 
benefit for carotid surgery in symptomatic patients with a 70% or greater stenosis [(2)]. This forms the 
basis of current clinical recommendations; however not all of these patients will benefit from 
surgicb;lal intervention. Improved quantification of an individual’s risk of future stroke would allow 
better patient selection for intervention. 
 
First established in 1982 [(3)], transcranial Doppler ultrasound (TCD) is an imaging technique used to 
detect the presence of small particles which may dislodge from an atherosclerotic plaque and flow 
into cerebral vessels. These microemboli reflect ultrasound more effectively than the surrounding cells 
giving a characteristic high intensity short duration signal on TCD. It is proposed that the presence of 
microemboli indicates an unstable or ‘vulnerable’ carotid plaque which may lead to rupture, thrombus 
formation or occlusion of the carotid artery resulting in a stroke [(4)]. Data suggest that microembolic 
signals (MES) recorded by TCD correlate with stroke risk. A potential link between the two has been 
known about for a long time, resulting in a significant amount of data. None of the studies performed 
so far have been definitive and therefore summation of the available evidence by meta-analysis will 
provide a better picture of the current evidence on the degree of correlation between MES on TCD 
and stroke risk. We performed a formal meta-analysis based on Cochrane methodological standards. 
 
A common criticism of TCD is that increased temporal bone thickness inhibits scanning in a certain 
proportion of patients. Therefore, we also investigated the incidence of this in the papers selected for 
meta-analysis. 
Objectives  
To determine the prognostic accuracy for stroke and/or TIA of MES recorded by TCD ultrasound in 
patients with carotid atherogenic disease. 
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To determine the feasibility of TCD ultrasound in patients with carotid disease by quantifying the 
temporal bone window availability in studies selected for the primary objective.  
 
Materials and Methods  
Ethical approval was not required for this paper. We conducted this review in accordance with 
PRISMA and Cochrane reporting guidelines. 
 
Study selection 
A multiple electronic health database search was performed using Medline (PubMed), Embase and 
The Cochrane Database. This included all prospective studies between 1990 and September 2015 
describing the use of TCD and the detection of MES in patients with carotid atherosclerosis.  
 
Search terms used were: 
(High intensity transient signals OR microembolic signal OR embolic signal OR transcranial Doppler 
OR transcranial ultrasound OR transcranial ultrasonography) 
AND 
(Amaurosis fugax OR transient ischaemic attack OR TIA OR carotid stenosis OR stroke) 
 
Two independent review authors assessed all papers returned by the search using the title and 
abstract. Any divergence was resolved through discussion. Full articles were selected if the abstract 
suggested the presence of relevant data. The reference lists of all included studies and previously 
published reviews were hand searched. 
 
Inclusion criteria 
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All prospective studies were included, irrespective of blinding, language, publication status or study 
setting. Any patient with atherosclerosis of the carotid artery, either directly evidenced or suspected 
as the cause of neurological damage was included in this review. 
 
Data pertaining to microemboli count and stroke and/or TIA was extracted using a physical criteria 
form. Temporal bone window availability data was extracted where available. 
 
Exclusion criteria 
Studies lacking TCD scan results or information of patient cerebrovascular events were excluded. Any 
papers which indicated the duplication of subjects from previous studies were excluded. 
 
Assessment of methodological quality  
Papers were assessed for risk of bias using the QUADAS-2 tool as found in the Revman Cochrane 
software(5).  
 
Statistical analysis and data synthesis  
Three analyses were proposed, all of which assessed the detection of MES by TCD in the middle 
cerebral artery. These investigated MES detection as a predictor of: 
1. Stroke or TIA; 
2. Stroke alone; and 
3. Stroke or TIA, with a higher positivity threshold (greater than ten microemboli) 
Subgroup analysis was proposed to compare pre-operative (symptomatic or asymptomatic) patients 
and peri- or post-operative patients. Due to the data collected, this was only possible in the stroke or 
TIA and the stroke only group. Division of patients into symptomatic and asymptomatic groups was 
also considered, however it would have likely meant that meta-analysis could not be performed 
because of the repeated division of results by category. 
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Data was managed using the Cochrane systematic review software, Revman 5.2. Analysis was 
performed using the METADAS procedure in SAS version 9.4 (SAS Institute Inc., Cary, North 
Carolina, USA). We used the bivariate random effects model for all analyses. This process was used 
to produce meta-analysis of data sensitivity, specificity, positive likelihood ratio and negative likelihood 
ratio. The likelihood ratio expresses the discriminatory value of a diagnostic test. A positive likelihood 
ratio of greater than five indicates that the test has high discriminatory value, whereas when the 
positive likelihood ratio approaches one, the test has no diagnostic value. The same is true for the 
negative likelihood ratio, with a value of 0.2 demonstrating high discriminatory power and a value 
approaching one representing little to no discriminatory power. The probability of any of the patients 
included in each analysis suffering an event (the pre-test probability) was calculated and multiplied by 
the positive and negative likelihood ratio to generate post-test probabilities. A positive post-test 
probability indicates the percentage chance of a cerebrovascular event in a patient with a positive 
TCD test for MES. A perfect test has a positive and negative post-test probability of 100 and 0 
respectively. We compared pre- and post-test probabilities in order to determine how useful the test is 
at identifying high risk and low risk patients. Extracted temporal bone window availability data was 
averaged across all patients scanned.  
Results  
Selected studies 
Three thousand two hundred and twenty-three papers were identified by the original search. This was 
reduced to 509 on abstract screening and 62 on full text assessment. A total of 28 studies provided 
data for meta-analysis. A flow diagram representing this can be found in figure 1. Of these, 22 papers, 
including 3720 patients, reported stroke or TIA as their target condition. Nineteen papers, with 5570 
patients, reported stroke as their target condition. Eight papers, with 1414 patients, reported stroke or 
TIA with a higher positivity threshold as their target condition. Several papers reported data for more 
than one of the three analyses in the same individuals. Since direct comparison of the different 
outcomes was not performed, the same data was used in multiple analyses. The characteristics of 
studies included for meta-analysis can be found in table 1 and table 2.  
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Methodological quality of included studies  
The results of QUADAS-2 assessment of papers are shown in figures 2 and 3. The quality of the 
evidence was generally low. Over 50% of studies had a high risk of bias for both patient selection and 
flow and timing sections of the QUADAS-2 protocol. In addition, there is unclear risk of bias for all 
studies with regards to the reference standard.  
 
Review authors' judgements about each domain presented as percentages across included studies. 
This graph summarizes the general quality of evidence with over 50% of selected papers at high risk 
of patient selection and flow and timing bias. Every paper had an unclear risk of bias with regards to 
the reference standard which is occurrence of stroke with or without TIA. Almost all papers were 
thought to be applicable to the review question. 
 
Findings 
There were three analyses performed. These were of TCD detection of MES as a predictor of: stroke 
or TIA, stroke alone, and stroke or TIA with increased positivity threshold. 
 
Stroke or TIA 
Twenty-two studies reported stroke or TIA as an outcome along with data for TCD recording of 
microembolic signals with a total of 3720 individual patients (6–26). The sensitivity and specificity 
were 79.87 (95% CI 63.39 to 90.09)* and 67.07 (95% CI 56.56 to 76.11)* respectively (* = P<0.05). 
The positive and negative likelihood ratios were 2.43 (95% CI 1.85 to 3.18)* and 0.30 (95% CI 0.16 to 
0.55)* respectively. The median pre-test probability for these studies was 6.7%. The corresponding 
positive and negative post-test probabilities were 14.8% (95% CI 11.7 to 18.6)* and 2.1% (95% CI 1.2 
to 3.8)* respectively. The results of the statistical analysis are detailed in table 3. Figure 4 shows how 
a positive and negative TCD test change the chance of a patient suffering stroke or TIA with a range 
of pre-test probabilities.  
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Subgroup analysis stroke or TIA 
The same analysis was performed separately for pre-operative patients and peri- and post-operative 
patients.  
For the preoperative group the sensitivity and specificity were 68.73 (95% CI 50 to 82.85) and 79.96 
(95% CI 72.24 to 85.95)* respectively. The positive and negative likelihood ratios were 3.43 (95% CI 
2.42 to 4.87)* and 0.39 (95% CI 0.23 to 0.66)* respectively. At the median pre-test probability of 6.7%, 
the post-test probabilities of a positive and negative test were 19.8% (95% CI 14.8 to 25.9)* and 2.7% 
(95% CI 1.6 to 4.5)* respectively. The full results are summarised in Summary of findings table 1. 
 
For the peri- and postoperative group the sensitivity and specificity were 89.61 (95% CI 70.8 to 
96.84)* and 46.38 (95% CI 35.27 to 57.85) respectively. The positive and negative likelihood ratios 
were 1.67 (95% CI 1.34 to 2.08)* and 0.22 (95% CI 0.07 to 0.67)* respectively. At the median pre-test 
probability of 6.7%, the post-test probabilities of a positive and negative test were 10.7% (95% CI 8.8 
to 13)* and 1.6% (95% CI 0.5 to 4.6)* respectively. The full results are summarised in Summary of 
findings table 1. 
 
The differences between subgroups were found to be significant with a Chi squared value of 0.001* 
derived from the differences in log likelihood ratios. 
 
Stroke 
Nineteen studies, with a total of 5570 individual patients, reported stroke as an outcome along with 
data for TCD recording of microembolic signals (7–10,13,16,18–20,23,27–34). The sensitivity and 
specificity were 73.14 (95% CI 48.16 to 88.86) and 70.27 (95% CI 58.61 to 79.78)* respectively. The 
positive and negative likelihood ratios were 2.46 (95% CI 1.69 to 3.59)* and 0.38 (95% CI 0.18 to 
0.81)* respectively. At the median pre-test probability of stroke of 3.0%, the post-test probabilities of a 
positive and negative TCD were 7.1% (95% CI 5 to 10.1)* and 1.2% (95% CI 0.6 to 2.5)* respectively. 
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The full results are summarised in table 4 with a graphical illustration of the corresponding post-test 
probabilities for various pre-test probabilities shown in figure 5. 
 
Subgroup analysis stroke 
The same analysis was performed separately for pre-operative patients and peri- and post-operative 
patients.  
 
For the preoperative group the sensitivity and specificity were 71.27 (95% CI 41.49 to 89.67) and 
83.72 (95% CI 76.61 to 88.98)* respectively. The positive and negative likelihood ratios were 4.38 
(95% CI 2.99 to 6.4)* and 0.34 (95% CI 0.15 to 0.81)* respectively. At the median pre-test probability 
of 3.0%, the post-test probabilities of a positive and negative test were 12% (95% CI 8.6 to 16.7)* and 
1.1% (95% CI 0.5 to 2.5)* respectively. The full results are summarised in Summary of findings table 
2. 
 
For the peri- and postoperative group the sensitivity and specificity were 78.86 (95% CI 44.75 to 94.5) 
and 47.43 (95% CI 35.69 to 59.46) respectively. The positive and negative likelihood ratios were 1.5 
(95% CI 1.12 to 2.02)* and 0.45 (95% CI 0.15 to 1.35) respectively. At the median pre-test probability 
of 3.0%, the post-test probabilities of a positive and negative test were 4.5% (95% CI 3.4 to 5.9)* and 
1.4% (95% CI 0.5 to 4) respectively. The full results are summarised in Summary of findings table 2 . 
 
The differences between subgroups were found to be significant with a Chi squared value of less than 
0.001 derived from the differences in log likelihood ratios. 
 
Stroke or TIA High MES Count 
Eight studies, with a total of 1414 individual patients, reported stroke or TIA as an outcome along with 
data for TCD recording of microembolic signals with high MES counts defined as positive(13,17–
19,21,32,33,35). The sensitivity and specificity were 52.38 (95% CI 30.59 to 73.29) and 90.07 (95% 
CI 83.72 to 94.12)* respectively. The positive and negative likelihood ratios were 5.27 (95% CI 2.73 to 
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10.17)* and 0.53 (95% CI 0.33 to 0.85)* respectively. At the median pre-test probability of 3.1%, the 
post-test probabilities of a positive and negative TCD were 14.4% (95% CI 8 to 24.5)* and 1.7% (95% 
CI 1.0 to 2.7)* respectively. The full results are summarised in table 5 with a graphical illustration of 
the corresponding post-test probabilities for various pre-test probabilities shown in figure 6. 
Temporal Bone Window 
Thirteen studies reported data relating to temporal bone window availability with a total of 2400 
patients. These papers showed an average of 89.0% of patients had a thin enough temporal bone for 
scanning. 
Discussion  
This review investigates whether TCD examination could play a clinically useful role in assessing the 
risk of stroke in patients with carotid disease. To do so it must differentiate between patients at high 
and low risk of future events.  
 
Quality of Evidence 
The general quality of the evidence was low. There were methodological issues with patient selection 
because of the observational nature of the data. Technical issues resulted in exclusions of patients 
which affected both patient selection and flow and timing (figure 2 and 3). For every study the risk of 
bias arising from the reference standard was unclear because it was generally unclear if the test was 
interpreted with or without knowledge of whether the patient suffered a stroke or TIA. Spence et al. 
2005, Spence et al. 2010 and Siebler et al. 1995 used two microemboli as positivity rather than one, 
and Sun et al. 2014 had TCD recordings for 30 minutes rather than an hour [5-8]. Whilst unlikely to 
skew the data it should be taken into account when interpreting results. Because of these issues the 
quality of evidence is low which should be considered when interpreting the results. 
 
Stroke or TIA 
The results are all statistically significantly different from a test which provides no useful information, 
i.e. a ‘fifty/fifty’ guess, therefore TCD does provide clinically useful information. As stated earlier the 
11 
 
 
low quality of evidence means these findings should be viewed cautiously. In addition, the important 
question is how much information is gained and whether this is enough to recommend its use. The 
nature of available evidence does not provide appropriate data for answering this question. To 
definitively quantify how useful a test is direct comparison with all alternative tests should be 
performed.  
 
The differences between studies with and without the covariate were found to be significant with a Chi 
squared value of 0.00045* derived from the differences in log likelihood ratios. This means that TCD 
has a different ability to predict stroke or TIA in preoperative patients and peri or postoperative 
patients. Recording done in peri or postoperative patients has superior sensitivity however the 
specificity is reduced. This is unsurprising as MES counts tend to be very high during surgery and in 
the immediate postoperative period because of the physical stress exerted on the plaque as well as 
iatrogenic sources of emboli. In this period the baseline number of microemboli that indicates high risk 
of plaque rupture is raised. This will result in fewer false negatives but more false positives as more 
patients will have microemboli. To take into account the differences between these two groups of 
patients it may be preferable to raise the baseline for positivity by requiring a certain microemboli rate 
before defining a peri- or post-operative patient as microemboli positive. 
 
Stroke 
TCD's specificity for predicting stroke was shown to be statistically significant. Sensitivity had a 
confidence interval which included 50 and therefore did not provide useful information in this regard. 
Further investigation is required to conclusively prove the utility of TCD in predicting stroke alone. This 
result is particularly important because prediction of stroke is clinically much more important than 
predicting stroke or TIA, as TIA is itself the gold standard for stroke prediction. What will actually save 
lives and brain function is the prediction of stroke not the prediction of TIA. Further investigation with 
stroke as the outcome alone is important. 
 
Subgroup analysis again revealed that TCD has a statistically significantly different ability to predict 
stroke in preoperative compared to peri or postoperative patients with a chi squared value less than 
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0.001. The same pattern emerges with decreased specificity in peri or postoperative patients but 
increased sensitivity, which provides validation of the data analysed because of the logical 
explanation for this repeated pattern. 
 
Stroke/TIA with high MES count 
Stroke or TIA with a high MES count for positivity threshold had a low sensitivity but high specificity 
(summary of findings table 3). The low sensitivity but high specificity is unsurprising due to the high 
baseline number of MES required for positivity meaning some patients with a few MES but not 
enough to be considered positive who have a stroke or TIA may be missed, however when a patient 
does have enough MES to be considered positive they are highly likely to suffer an event. It may be 
hypothesised that raising the baseline for MES positivity is most effective in peri- and post-operative 
patients. Unfortunately subgroup analysis was not possible for this outcome because the fixed effects 
bivariate model was considered inappropriate and using a random effects model makes covariate 
analysis unreliable.  
 
Strengths and weaknesses of the review  
King & Markus 2009 is the main review for comparison [(36)]. There is general overall agreement in 
both stroke and TIA and stroke as outcomes being predicted by MES presence. For the high MES 
threshold analysis King and Markus included papers with widely varying definitions of high 
microemboli rate and therefore included considerably more papers than the current review. This 
enabled them to find statistical significance in all subgroups. The heterogeneity which would be 
expected when included such a diverse number of studies may have been masked by the fact that the 
majority of papers reported no false positives which will cause the results to produce statistically 
similar odds ratios. 
The interval between MES recording and start of symptoms has not been taken into account in the 
analysis. This may provide further useful information when interpreting TCD results, however it was 
not considered within the scope of this study. Anti-platelet therapy may provide an additional 
confounder, as it is hypothesised that it may impact the number of MES. It was not investigated as 
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current evidence indicates that number of MES may not be changed by antiplatelet therapy(37), 
however if this were to change, the implications for use of TCD will be significant. 
 
Applicability of findings to the review question  
This review included a wide variety of patients. The evidence proves that TCD is predictive of stroke 
and TIA in both preoperative and peri and postoperative patients separately. TCD provides predictive 
information for stroke and for preoperative patients. There is not enough evidence to demonstrate that 
TCD provides predictive information for stroke in peri and postoperative patients because of a low 
specificity. It is unclear if there is genuinely too low a specificity for TCD to provide useful information 
in these patients. The low quality of evidence and number of studies means more high quality studies 
are required to explore this further. 
Conclusions  
This review demonstrates that TCD provides useful clinical evidence for the prediction of stroke and 
TIA. The weakness of the current evidence base means that more work is necessary in order to 
incorporate TCD into assessment of patients with carotid disease.  
 
The low level of evidence means large scale randomised control trials are required to establish TCD 
as an effective adjunct indicator of stroke along with carotid stenosis. Until clinical benefit over current 
predictors can be conclusively proved and quantified TCD cannot be adopted into clinical guidelines 
and therefore will not be universally applied. Future carotid trials need to establish a series of 
indicators which can be compiled into an accurate risk score of future stroke for each patient. Such 
indicators would include stenosis, TCD and physical plaque characteristics. An effective risk score for 
all patients with carotid disease will expedite the stroke response pathway which currently requires 
multidisciplinary collaboration because of the qualitative nature of alternative risk factors besides 
stenosis. Fast and effective risk assessment will enable a decrease in time from symptoms to surgery, 
ensuring the best possible patient outcome. 
Acknowledgements 
14 
 
 
Professor Martin Brown and Dr Anne Huibers. 
There are no sources of funding for the research discussed in the study . 
There is no conflict of interest. 
 
Abbreviations and symbols 
* statistical significance at the 95% confidence level when compared to random chance 
˂ indicates a number which whilst it rounds to a non-significant value the number itself is actually 
significant i.e. if the significance threshold is 1 0.99 will round up to 1.0 however it is still significant to 
a 95% confidence level. 
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